Publication:
The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment

Placeholder

Date

Organizational Units

Authors

Gürel, Selim

Authors

Marcellin, Patrick
Bonino, Ferruccio
Lau, George
Farci, Patrizia
Yurdaydin, C.
Piratvisuth, Teerha
Jin, R.
Hadziyannis, Stephanos J.
Lu, Zhimeng
Popescu, Madalina

Advisor

Language

Publisher:

Elsevier

Journal Title

Journal ISSN

Volume Title

Abstract

Description

Bu çalışma, 26-30 Nisan 2006 tarihleri arasında Vienna[Avusturya]’da düzenlenen 41. Annual Meeting of the European-Association-for-the-Study-of-the-Liver’da bildiri olarak sunulmuştur.

Source:

Keywords:

Keywords

Gastroenterology & hepatology

Citation

Marcellin, P. vd. (2006). ''The majority of patients with HBeAg-negative chronic hepatitis B treated with peginterferon alpha-2a (40KD) [PEGASYS (R)] sustain responses 2 years post-treatment''. Journal of hepatology, 44(Suplement 2), S275-S275.

Endorsement

Review

Supplemented By

Referenced By

0

Views

0

Downloads